Clinical forecasting is now leveraging innovative informatics capabilities for more precise recruitment and endpoint projections during a study’s crucial…


Megamerger-happy investors bid up AZ shares on speculation that Novartis might try a takeover

Novartis CEO predicts drug pricing overhaul in U.S. after the election, whoever wins

FDA rejects Sandoz's Neulasta copy, giving Amgen a break from the biosim onslaught

UPDATED: Novartis warns profits may slip as it bets an extra $200M on Entresto

FDA staffers like Sandoz' biosimilarity data for copy of Amgen's Enbrel

Sandoz's Enbrel biosim hits its sought-after equivalence mark in psoriasis

Novartis enlists body painter to showcase psoriasis patient testimonies

Medivation opens its books to would-be buyers, including the formerly hostile Sanofi

Bristol-Myers' Opdivo falls short at NICE, thanks to Pfizer's Inlyta discount

Lilly's Trulicity joins pay-for-performance trend with Harvard Pilgrim deal